π’ Welcome to Pharmidex, Ty Hoffmann!
June 25, 2026
We are pleased to welcome Ty Hoffmann to
Pharmidex as our new Business Development Associate (US).
Ty recently graduated from Fisher College with a Bachelor’s degree in Cybersecurity and joins us with experience in sales, business development, and client engagement. His background combines commercial awareness with strong analytical and technical skills, making him a great addition to our growing team.
As
Pharmidex continues to expand its presence across North America, Ty will focus on building new client relationships and supporting organisations seeking high-quality preclinical drug discovery and development services.
We are excited to have Ty on board and look forward to supporting his growth and success within the business.
Please join us in welcoming him to the
Pharmidex team!
#BusinessDevelopment #Pharmidex #DrugDiscovery #PreclinicalResearch #CRO #Biotech #LifeSciences #USExpansion
πβοΈβοΈ Congratulations to our Pharmidex team members who took part in the St Albans Summer Solstice 10K #BeatTheSunset ! It was great to see colleagues enjoying a fantastic summer evening while supporting their physical and mental wellbeing. At Pharmidex , we believe health extends beyond the laboratory and activities like these are a great way to stay active, connect with colleagues and have fun. Well done to everyone who took part and represented Pharmidex so positively!
A big thank you to our interns from City St George’s, University of London and heir fantastic contribution to Pharmidex over the past few months. They have supported scientific projects across the business, developed valuable technical skills and gained hands-on experience within a CRO environment. Their contribution has extended beyond the laboratory, helping with our website, marketing materials, conference preparation and business development activities. Science drives success, but communicating that science effectively is just as important. Our interns have helped us do both. Thank you for your hard work, enthusiasm, and dedication. We wish you every success in the next stage of your careers.
On 18 June, our COO, Ash Alavijeh , will join an industry panel discussing: "What are the advantages and disadvantages of working with UK-based Discovery CROs?" The session will explore the value of UK CROs in supporting innovation, protecting IP, accessing scientific expertise and accelerating drug discovery programmes. π
18 June 2025 π Cambridge π Panel Session: 12:20–12:45 We look forward to connecting with colleagues, collaborators, and innovators from across the life sciences community.
